Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypersensitivity in eosinophilic esophagitis
NL-OMON49677Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of budesonide in eosinophilic esophagitis (EoE) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Perfusion sensitivity score and Balloon distension discomfort threshold. Started Nov 2020; status: active, not recruiting.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NL-OMON49677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49677.